跳转至内容
Merck
CN

PZ0234

PF-543 盐酸盐

≥98% (HPLC), sphingosine kinase-1 inhibitor, powder

别名:

PF-05144543 盐酸盐, (2R)-1-[[[4-[[3-甲基-5-[(苯磺酰基)甲基]苯氧基]甲基]苯基]甲基] -2-吡咯烷甲醇 盐酸盐, (R)-(1-(4-((3-甲基-5-(苯磺酰基甲基)苯氧基)甲基)苄基)吡咯烷-2-基)甲醇 盐酸盐

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C27H31NO4S · HCl
化学文摘社编号:
分子量:
502.07
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
Quality level:
Storage condition:
desiccated
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

PF-543 盐酸盐, ≥98% (HPLC)

Quality Level

assay

≥98% (HPLC)

form

powder

storage condition

desiccated

color

white to light brown

solubility

H2O: 20 mg/mL, clear

storage temp.

−20°C

SMILES string

[H]Cl.CC1=CC(OCC2=CC=C(CN3[C@@H](CO)CCC3)C=C2)=CC(CS(C4=CC=CC=C4)(=O)=O)=C1

InChI

1S/C27H31NO4S.ClH/c1-21-14-24(20-33(30,31)27-7-3-2-4-8-27)16-26(15-21)32-19-23-11-9-22(10-12-23)17-28-13-5-6-25(28)18-29;/h2-4,7-12,14-16,25,29H,5-6,13,17-20H2,1H3;1H/t25-;/m1./s1

InChI key

WNKWAZFYPZMDGJ-VQIWEWKSSA-N

Biochem/physiol Actions

PF-543可刺激微管相关蛋白轻链3(LC3)的颗粒积累。它还会诱导LC3-I向LC3-II的转化,并受到自噬抑制剂,渥曼青霉素、3-甲基腺嘌呤(3-MA)和巴氟霉素A1的抑制。在人的头颈部鳞状细胞癌(SCC)细胞中,PF-543盐酸盐可促进坏死、凋亡和自噬。
PF-543盐酸盐是一种全新的、细胞可渗透的、有效的、选择性的鞘氨醇激酶-1(SphK1)抑制剂。
PF-543盐酸盐是一种全新的、细胞可渗透的、有效的、选择性的鞘氨醇激酶-1(SphK1)抑制剂。 PF-543可抑制SphK1,其Ki值为3.6 nM,其与鞘氨醇具有竞争性,对SphK1的选择性是SphK2同种型的100倍以上。PF-543可将内源性S1P的水平降低10倍,并与鞘氨醇的水平成比例地增加。


存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Yuliya Fakhr et al.
International journal of molecular sciences, 23(7) (2022-04-13)
Preeclampsia (PE) involves inadequate placental function. This can occur due to elevated pro-inflammatory tumor necrosis factor-α (TNF-α). In other tissues, TNF-α signals via sphingosine kinase 1 (SphK1). SphK1 hinders syncytial formation. Whether this occurs downstream of TNF-α signaling is unclear.
Induction of autophagy by sphingosine kinase 1 inhibitor PF-543 in head and neck squamous cell carcinoma cells.
Hamada M. et al,
Cell death discovery, 3, 17047-17047 (2017)
Stephen J Blake et al.
Cell reports. Medicine, 2(12), 100464-100464 (2022-01-15)
Immune agonist antibodies (IAAs) are promising immunotherapies that target co-stimulatory receptors to induce potent anti-tumor immune responses, particularly when combined with checkpoint inhibitors. Unfortunately, their clinical translation is hampered by serious dose-limiting, immune-mediated toxicities, including high-grade and sometimes fatal liver



全球贸易项目编号

货号GTIN
PZ0234-25MG04061832449326
PZ0234-5MG04061832449333